ZKB/CALL/MODERNA/130/0.025/28.06.24 Stock

Warrant

MRNCAZ

CH1338498715

Market Closed - Swiss Exchange 11:20:01 2024-06-06 am EDT
0.62 CHF +21.57% Intraday chart for ZKB/CALL/MODERNA/130/0.025/28.06.24
Current month+31.91%

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MODERNA, INC.
Issuer ZKB
MRNCAZ
ISINCH1338498715
Date issued 2024-05-06
Strike 130 $
Maturity 2024-06-28 (13 Days)
Parity 40 : 1
Emission price 0.18 CHF
Emission volume N/A
Settlement cash
Currency CHF

Technical Indicators

Highest since issue 0.88 CHF
Lowest since issue 0.11 CHF

Company Profile

Moderna, Inc. is a biotechnology company specialized in research and development of therapeutics and vaccines for cancer, infectious, autoimmune and cardiovascular diseases. Net sales break down by type of revenue as follows: - revenue from product sales (95.7%) ; - revenues from grants (4%); - revenues from collaboration agreements (0.3%). At the end of 2021, the group possessed a portfolio of 15 products in clinical development, of which 3 in phase III, 8 in phase II and 4 in phase I, and 12 products in preclinical development. Net sales are distributed geographically as follows: the United States (33.4%), Europe (37.1%) and other (29.5%).
Sector
-
More about the company

Ratings for Moderna, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Moderna, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
140 USD
Average target price
145.2 USD
Spread / Average Target
+3.67%
Consensus
  1. Stock Market
  2. Warrants
  3. MRNCAZ Warrant